货号：UP534497988
| 产品信息 | |
| 产品名称： | IRAK inhibitor 4 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 1012104-68-5 |
| 分子式： | C33H35F3N6O3 |
| 分子量： | 620.66 |
| MDL NO： | - |
| 标准纯度： | 98+% (UP534497988) |
| 沸点： | - |
| 储存： | (UP534497988) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
AR-A014418
UP811305347487021-52-3
DC260126
UP886509268346692-04-4
Racecadotril
UP44119095481110-73-8
RQ-00203078
UP2042800821254205-52-1
Purvalanol A
UP891455538212844-53-6
2,6-Di-tert-butyl-4-methylphenol
UP659308442128-37-0
cis-Octahydro-1H-pyrrolo[3,4-b]pyridine
UP606488988147459-51-6
Derazantinib
UP2301213551234356-69-4
Decahydroquinoline
UP4630482302051-28-7
DC_05
UP222552199890643-16-0
N-Acetylprocainamide
UP59827795732795-44-1
MSI-1436
UP975738383186139-09-3
Phenethyl methanesulfonate
UP65708084320020-27-3
3-Fluoro-N-hydroxybenzimidoyl chloride
UP81213853858606-42-1
LY2801653
UP5546253841206799-15-6
2-(Methylthio)benzo[d]oxazole
UP84995608413673-62-6
2-(2-((4-Fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetic acid
UP850776281356058-42-9
Nexturastat A
UP7146323681403783-31-2
Reparixin
UP317430600266359-83-5
N-(5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)methanesulfonamide hydrobromide
UP210330648107756-30-9
HMN-214
UP685240787173529-46-9
GW1100
UP716425014306974-70-9
Etravirine D4
UP3134905731142095-93-9
tert-Butyl 3-cyanoazetidine-1-carboxylate
UP382362828142253-54-1
2,6,10,10-Tetramethyl-1-oxaspiro[4.5]dec-6-ene
UP88680899536431-72-8
4-Amino-5-(ethylsulfonyl)-2-methoxybenzoic acid
UP75939932471675-87-1
GPR119 Agonist C26
UP2370981141353004-92-8
Aprepitant
UP658939994170729-80-3
Sal003
UP1729589041164470-53-4
Nordihydroguaiaretic acid
UP199758732500-38-9
Formylhydrazine
UP464974644624-84-0
5-Methylisoxazole-4-carbonyl chloride
UP37797232567305-24-2
KPT-8602
UP7761965621642300-52-4
Dorsomorphin
UP399500061866405-64-3
Cefditoren sodium
UP327326131104146-53-4
Oseltamivir acid
UP146406724187227-45-8
PD149163
UP664479524169528-11-4
Periglaucine A
UP6479047711025023-04-4
Boc-Met-OH
UP2583425872488-15-5
GPR120 modulator 2
UP1530001121050506-87-0
Sanilvudine
UP6662094293056-17-5
Fexaramine
UP594705487574013-66-4
SR-3306
UP4582453961128096-91-2
MK-0812
UP714861291624733-88-6
3,5-Dimethylisoxazole-4-sulfonyl chloride
UP54128267280466-79-1
Bis(acetoxymethyl) 2,2'-((2-(5-((acetoxymethoxy)carbonyl)oxazol-2-yl)-5-(2-(2-(bis(2-(acetoxymethoxy)-2-oxoethyl)amino)-
UP5360770580108964-32-5
((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
UP8410734121103738-19-7
Ansamitocin P-3'
UP81569573066547-09-9
Tasimelteon
UP796008767609799-22-6
N-Hydroxy-4-methanesulfonylbenzene-1-carboximidamide
UP98158844556935-74-1
KML29
UP4721793311380424-42-9
RG108
UP82343794248208-26-0
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihyd
UP53564657233069-62-4
6-OAU
UP59518329583797-69-7
CYM-5442
UP3241855191094042-01-9
PF-04691502
UP9503565511013101-36-4
CY2
UP676996008260430-02-2
Quinapril Hydrochloride
UP72739483482586-55-8
Epibrassinolide
UP34314749178821-43-9
1NM-PP1(PP1 Analog II)
UP807951294221244-14-0
Phosalone
UP7817729692310-17-0
3-Nitro-4,5-dihydroisoxazole
UP6670736301121-14-8
Cyproterone acetate
UP621183248427-51-0
Felbamate hydrate
UP6659999481177501-39-1
APD597
UP719312321897732-93-3
(1S,2R)-2-Amino-1,2-diphenylethanol
UP87875748523364-44-5
Clevudine
UP620361365163252-36-6
Belinostat
UP332439503866323-14-0
CUDC-907
UP6375659701339928-25-4
Indigo
UP742459064482-89-3
IRAK inhibitor 4
UP5344979881012104-68-5